ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 190 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $849,418 | -63.6% | 40,759 | -58.2% | 0.11% | -66.7% |
Q2 2023 | $2,335,245 | -25.7% | 97,505 | -41.6% | 0.32% | -24.6% |
Q1 2023 | $3,142,846 | +565.0% | 166,995 | +462.5% | 0.43% | +453.2% |
Q4 2022 | $472,601 | +24.0% | 29,686 | +27.5% | 0.08% | +32.8% |
Q3 2022 | $381,000 | -68.9% | 23,286 | -73.2% | 0.06% | -46.3% |
Q2 2022 | $1,226,000 | -79.3% | 87,008 | -64.5% | 0.11% | -78.8% |
Q1 2022 | $5,930,000 | +34.3% | 244,825 | +29.4% | 0.51% | +51.8% |
Q4 2021 | $4,414,000 | +19.1% | 189,128 | -15.2% | 0.34% | +26.3% |
Q3 2021 | $3,706,000 | +203.8% | 223,130 | +346.3% | 0.27% | +228.4% |
Q2 2021 | $1,220,000 | -88.5% | 50,000 | -90.2% | 0.08% | -81.6% |
Q3 2018 | $10,637,000 | +2.2% | 512,358 | -24.8% | 0.44% | +11.6% |
Q2 2018 | $10,407,000 | -24.2% | 681,500 | +11.6% | 0.40% | -14.7% |
Q1 2018 | $13,722,000 | +218.7% | 610,700 | +405.7% | 0.46% | -21.5% |
Q4 2015 | $4,305,000 | +153.1% | 120,771 | +134.8% | 0.59% | +1452.6% |
Q3 2015 | $1,701,000 | -73.3% | 51,431 | -66.1% | 0.04% | -77.1% |
Q2 2015 | $6,360,000 | – | 151,852 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |